International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(18), P. 10729 - 10729
Published: Sept. 14, 2022
Gut
microbiota
dysbiosis
has
recently
been
reported
in
a
number
of
clinical
states,
including
neurological,
psychiatric,
cardiovascular,
metabolic
and
autoimmune
disorders.
Yet,
it
is
not
completely
understood
how
colonizing
microorganisms
are
implicated
their
pathophysiology
molecular
pathways.
There
suggested
mechanisms
gut
triggers
or
sustains
extraintestinal
diseases;
however,
none
these
have
widely
accepted
as
part
the
disease
pathogenesis.
Recent
studies
proposed
that
its
metabolites
could
play
pivotal
role
modulation
immune
system
responses
development
autoimmunity
diseases
such
rheumatoid
arthritis,
multiple
sclerosis
type
1
diabetes.
Fecal
transplantation
(FMT)
valuable
tool
for
uncovering
pathological
processes.
This
review
aims
to
summarize
current
knowledge
about
potential
FMT
studying
pathogeneses
therapies
diseases.
Herein,
we
discuss
pathologies
with
at
least
one
published
ongoing
study
human
animal
models.
Critical Reviews in Microbiology,
Journal Year:
2022,
Volume and Issue:
49(2), P. 151 - 176
Published: March 11, 2022
The
role
of
Akkermansia
muciniphila,
one
the
most
abundant
microorganisms
intestinal
microbiota,
has
been
studied
extensively
in
metabolic
diseases,
such
as
obesity
and
diabetes.
It
is
considered
a
next-generation
probiotic
microorganism.
Although
its
mechanism
action
not
fully
elucidated,
accumulating
evidence
indicates
important
A.
muciniphila
brain
functions
via
gut-brain
axis
potential
therapeutic
target
various
neuropsychiatric
disorders.
However,
only
limited
number
studies,
particularly
clinical
have
directly
assessed
effects
interventions
these
This
first
review
to
discuss
comprehensive
protection
mucosal
barrier
modulation
immune
system
metabolites,
short-chain
fatty
acids,
amino
acid
derivatives.
Additionally,
disorders,
including
Alzheimer's
disease
cognitive
deficit,
amyotrophic
lateral
sclerosis,
Parkinson's
disease,
multiple
discussed.
suggests
healthy
functions.
iScience,
Journal Year:
2022,
Volume and Issue:
25(3), P. 103908 - 103908
Published: Feb. 11, 2022
The
gut
microbiota
influence
neurodevelopment,
modulate
behavior,
and
contribute
to
neurodegenerative
disorders.
Several
studies
have
consistently
reported
a
greater
abundance
of
Akkermansia
muciniphila
in
Parkinson
disease
(PD)
fecal
samples.
Therefore,
we
investigated
whether
A.muciniphila-conditioned
medium
(CM)
could
initiate
α-synuclein
(αSyn)
misfolding
enteroendocrine
cells
(EEC)
—
component
the
epithelium
featuring
neuron-like
properties.
We
found
that
A.
CM
composition
is
influenced
by
ability
strain
degrade
mucin.
Our
vitro
experiments
showed
protein-enriched
fraction
mucin-free
induces
RyR-mediated
Ca2+
release
increased
mitochondrial
uptake
leading
ROS
generation
αSyn
aggregation.
Oral
administration
cultivated
absence
mucin
mice
led
aggregation
cholecystokinin
(CCK)-positive
EECs
but
no
motor
deficits
were
observed.
Noteworthy,
buffering
reverted
damaging
effects
These
molecular
insights
offer
evidence
bacterial
proteins
can
induce
EECs.
Multiple Sclerosis Journal - Experimental Translational and Clinical,
Journal Year:
2022,
Volume and Issue:
8(2)
Published: April 1, 2022
Patients
with
MS
have
an
altered
gut
microbiota
compared
to
healthy
individuals,
as
well
elevated
small
intestinal
permeability,
which
may
be
contributing
the
development
and
progression
of
disease.We
sought
investigate
if
fecal
transplantation
was
safe
tolerable
in
patients
it
could
improve
abnormal
permeability.Nine
were
recruited
provided
monthly
FMTs
for
up
six
months.
The
primary
outcome
investigated
change
peripheral
blood
cytokine
concentrations.
secondary
outcomes
composition,
safety
(assessed
EDSS
MRI).The
study
terminated
early
subsequently
underpowered
assess
whether
cytokines
following
FMTs.
this
group
patients.
Two
five
had
permeability
at
baseline
that
improved
normal
values
Significant,
donor-specific,
beneficial
alterations
patient
observed
FMT.FMT
cohort
RRMS
patients,
has
potential
enrich
MS-protective
microbiota.
Further
studies
longer
follow-up
larger
sample
sizes
are
required
determine
FMT
is
a
suitable
therapy
MS.
Microbiome,
Journal Year:
2022,
Volume and Issue:
10(1)
Published: Oct. 17, 2022
Abstract
Background
The
gut
microbiome
plays
an
important
role
in
autoimmunity
including
multiple
sclerosis
and
its
mouse
model
called
experimental
autoimmune
encephalomyelitis
(EAE).
Prior
studies
have
demonstrated
that
the
microbiota
can
contribute
to
disease,
hence
making
it
a
potential
therapeutic
target.
In
addition,
antibiotic
treatment
has
been
shown
ameliorate
disease
EAE
of
sclerosis.
Yet,
this
date,
mechanisms
mediating
these
effects
are
not
understood.
Furthermore,
there
is
no
consensus
on
gut-derived
bacterial
strains
drive
neuroinflammation
Results
Here,
we
characterized
untreated
vancomycin-treated
mice
over
time
identify
bacteria
with
neuroimmunomodulatory
potential.
We
observed
alterations
composition
following
induction.
found
vancomycin
ameliorates
EAE,
protective
effect
mediated
via
microbiota.
Notably,
increased
abundance
known
be
strong
inducers
regulatory
T
cells,
members
Clostridium
clusters
XIVa
XVIII
during
presymptomatic
phase
as
well
at
peak.
identified
50
taxa
correlate
severity.
Interestingly,
several
exist
human
gut,
some
them
implicated
Anaerotruncus
colihominis
,
butyrate
producer
which
had
positive
correlation
associated
induction
RORγt
+
cells
mesenteric
lymph
nodes.
Conclusions
potent
modulator
gut-brain
axis
by
promoting
proliferation
species
induce
cells.
our
findings
reveal
commensals
regulator
used
further
characterize
pathogenic
beneficial
host-microbiota
interactions
patients.
Our
suggest
elevated
patients
may
represent
mechanism
recovery
from
disease.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(18), P. 10729 - 10729
Published: Sept. 14, 2022
Gut
microbiota
dysbiosis
has
recently
been
reported
in
a
number
of
clinical
states,
including
neurological,
psychiatric,
cardiovascular,
metabolic
and
autoimmune
disorders.
Yet,
it
is
not
completely
understood
how
colonizing
microorganisms
are
implicated
their
pathophysiology
molecular
pathways.
There
suggested
mechanisms
gut
triggers
or
sustains
extraintestinal
diseases;
however,
none
these
have
widely
accepted
as
part
the
disease
pathogenesis.
Recent
studies
proposed
that
its
metabolites
could
play
pivotal
role
modulation
immune
system
responses
development
autoimmunity
diseases
such
rheumatoid
arthritis,
multiple
sclerosis
type
1
diabetes.
Fecal
transplantation
(FMT)
valuable
tool
for
uncovering
pathological
processes.
This
review
aims
to
summarize
current
knowledge
about
potential
FMT
studying
pathogeneses
therapies
diseases.
Herein,
we
discuss
pathologies
with
at
least
one
published
ongoing
study
human
animal
models.